 |
|
Incidence of Adverse Effects and Discontinuation Rate between Patients Receiving 250 Micrograms and 500 Micrograms of Roflumilast: A Comparative Study
Hyonsoo Joo, Deokjae Han, Jae Ha Lee, Chin Kook Rhee
Tuberc Respir Dis. 2018;81(4):299-304. Published online 2018 Jun 19 DOI: https://doi.org/10.4046/trd.2018.0015
|
|
Citations to this article as recorded by
 The Dosing Strategy to Improve Adherence to Roflumilast in Treatment for Chronic Obstructive Lung Disease: A Systemic Review and Meta-Analysis
Jonghoo Lee, Jae-Uk Song
International Journal of Chronic Obstructive Pulmonary Disease.2024; Volume 19: 655. CrossRef cAMP-PDE signaling in COPD: Review of cellular, molecular and clinical features
Yazdan Hasani Nourian, Jafar Salimian, Ali Ahmadi, Zahra Salehi, Mehrdad Karimi, Alireza Emamvirdizadeh, Sadegh Azimzadeh Jamalkandi, Mostafa Ghanei
Biochemistry and Biophysics Reports.2023; 34: 101438. CrossRef 360-Degree Perspectives on Obesity
Magdalena Cuciureanu, Cătălin-Cezar Caratașu, Levon Gabrielian, Otilia Elena Frăsinariu, Laura Elisabeta Checheriță, Laura Mihaela Trandafir, Gabriela Dumitrița Stanciu, Andrei Szilagyi, Ina Pogonea, Gabriela Bordeianu, Radu Petru Soroceanu, Călin Vasile
Medicina.2023; 59(6): 1119. CrossRef Effectiveness of Roflumilast in Treating Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
Sumbal Naseem, Muhammad Hassan, Shazia Nasim Akhtar, Fibhaa Syed, Naveed Ullah Khan, Muhammad Usman
Cureus.2022;[Epub] CrossRef Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases
Kartik Deshmukh, Arjun Khanna
Tuberculosis and Respiratory Diseases.2021; 84(1): 35. CrossRef Roflumilast Ameliorates Isoflurane-Induced Inflammation in Astrocytes via the CREB/BDNF Signaling Pathway
Chunyuan Zhang, Zeting Xing, Meiyun Tan, Yanwen Wu, Wei Zeng
ACS Omega.2021; 6(6): 4167. CrossRef Updated view on the treatment of chronic obstructive pulmonary disease in Korea
Deog Kyeom Kim, Chin Kook Rhee
Journal of the Korean Medical Association.2021; 64(3): 225. CrossRef Spanish clinical practice consensus in internal medicine on chronic obstructive pulmonary disease patients with comorbidities (miEPOC)
Jesús Recio Iglesias, Francisco López García, Pere Almagro, José Manuel Varela Aguilar, Ramón Boixeda Viu
Current Medical Research and Opinion.2020; 36(6): 1033. CrossRef Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease
Chin Kook Rhee, Deog Kyeom Kim
The Korean Journal of Internal Medicine.2020; 35(2): 276. CrossRef Management of COPD in Asia: A position statement of the Asian Pacific Society of Respirology
Chin Kook Rhee, Ngo Quy Chau, Faisal Yunus, Kazuto Matsunaga, Diahn‐Warng Perng
Respirology.2019; 24(10): 1018. CrossRef Roflumilast
Reactions Weekly.2018; 1732(1): 310. CrossRef
|